|
1
|
de Vincentiis M, De Virgilio A, Bussu F,
Gallus R, Gallo A, Bastanza G, Parrilla C, Greco A, Galli J,
Turchetta R, et al: Oncologic results of the surgical salvage of
recurrent laryngeal squamous cell carcinoma in a multicentric
retrospective series: Emerging role of supracricoid partial
laryngectomy. Head Neck. 37:84–91. 2015. View Article : Google Scholar
|
|
2
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kang Y and Massague J:
Epithelial-mesenchymal transitions: Twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vandewalle C, Comijn J, De Craene B,
Vermassen P, Bruyneel E, Andersen H, Tulchinsky E, Van Roy F and
Berx G: SIP1/ZEB2 induces EMT by repressing genes of different
epithelial cell-cell junctions. Nucleic Acids Res. 33:6566–6578.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chu PY, Hu FW, Yu CC, Tsai LL, Yu CH, Wu
BC, Chen YW, Huang PI and Lo WL: Epithelial-mesenchymal transition
transcription factor ZEB1/ZEB2 co-expression predicts poor
prognosis and maintains tumor-initiating properties in head and
neck cancer. Oral Oncol. 49:34–41. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li JJ, Zhang GH, Yang XM, Li SS, Liu X,
Yang QT, Li Y and Ye J: Reduced E-cadherin expression is associated
with lymph node metastases in laryngeal squamous cell carcinoma.
Auris Nasus Larynx. 39:186–192. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Creighton CJ, Gibbons DL and Kurie JM: The
role of epithelial-mesenchymal transition programming in invasion
and metastasis: A clinical perspective. Cancer Manag Res.
5:187–195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Thiery JP, Chua K, Sim WJ and Huang R:
Epithelial mesenchymal transition during development in fibrosis
and in the progression of carcinoma. Bull Cancer. 97:1285–1295.
2010.PubMed/NCBI
|
|
10
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nguyen PT, Kudo Y, Yoshida M, Kamata N,
Ogawa I and Takata T: N-cadherin expression is involved in
malignant behavior of head and neck cancer in relation to
epithelial-mesenchymal transition. Histol Histopathol. 26:147–156.
2011.PubMed/NCBI
|
|
14
|
Zidar N, Boštjančič E, Gale N, Kojc N,
Poljak M, Glavač D and Cardesa A: Down-regulation of microRNAs of
the miR-200 family and miR-205, and an altered expression of
classic and desmosomal cadherins in spindle cell carcinoma of the
head and neck-hallmark of epithelial-mesenchymal transition. Hum
Pathol. 42:482–488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cappellesso R, Marioni G, Crescenzi M,
Giacomelli L, Guzzardo V, Mussato A, Staffieri A, Martini A,
Blandamura S and Fassina A: The prognostic role of the
epithelial-mesenchymal transition markers E-cadherin and Slug in
laryngeal squamous cell carcinoma. Histopathology. 67:491–500.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Comijn J, Berx G, Vermassen P, Verschueren
K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D and van Roy
F: The two-handed E box binding zinc finger protein SIP1
downregulates E-cadherin and induces invasion. Mol Cell.
7:1267–1278. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Greene FL, Page DL, Fleming ID, Fritz A,
Balch CM, Haller DG and Morrow M: American Joint Committee on
Cancer: AJCC Cancer Staging Manual. 6th. Chapter 2. Springer; New
York, NY: pp. 47–57. 2002
|
|
18
|
Goulioumis AK, Varakis J, Goumas P and
Papadaki H: Differential beta-catenin expression between glottic
and supraglottic laryngeal carcinoma. Eur Arch Otorhinolaryngol.
267:1573–1578. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ahmed RA, Shawky Ael-A and Hamed RH:
Prognostic significance of cyclin D1 and E-cadherin expression in
laryngeal squamous cell carcinoma. Pathol Oncol Res. 20:625–633.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kong YH, Syed Zanaruddin SN, Lau SH,
Ramanathan A, Kallarakkal TG, Vincent-Chong VK, Wan Mustafa WM,
Abraham MT, Abdul Rahman ZA, Zain RB and Cheong SC: Co-Expression
of TWIST1 and ZEB2 in oral squamous cell carcinoma is associated
with poor survival. PLoS One. 10:e01340452015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nieto MA: The ins and outs of the
epithelial to mesenchymal transition in health and disease. Annu
Rev Cell Dev Biol. 27:347–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Voulgari A and Pintzas A:
Epithelial-mesenchymal transition in cancer metastasis: Mechanisms,
markers and strategies to overcome drug resistance in the clinic.
Biochim Biophys Acta. 1796:75–90. 2009.PubMed/NCBI
|
|
25
|
Kurtz KA, Hoffman HT, Zimmerman MB and
Robinson RA: Decreased E-cadherin but not beta-catenin expression
is associated with vascular invasion and decreased survival in head
and neck squamous carcinomas. Otolaryngol Head Neck Surg.
134:142–146. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Psyrri A, Kotoula V, Fountzilas E,
Alexopoulou Z, Bobos M, Televantou D, Karayannopoulou G, Krikelis
D, Markou K, Karasmanis I, et al: Prognostic significance of the
Wnt pathway in squamous cell laryngeal cancer. Oral Oncol.
50:298–305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Greco A, De Virgilio A, Rizzo MI, Pandolfi
F, Rosati D and de Vincentiis M: The prognostic role of E-cadherin
and β-catenin overexpression in laryngeal squamous cell carcinoma.
Laryngoscope. 126:E148–E155. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Goulioumis AK, Fuxe J, Varakis J, Repanti
M, Goumas P and Papadaki H: Estrogen receptor-beta expression in
human laryngeal carcinoma: Correlation with the expression of
epithelial-mesenchymal transition specific biomarkers. Oncol Rep.
22:1063–1068. 2009.PubMed/NCBI
|
|
29
|
Yu L, Li HZ, Lu SM, Tian JJ, Ma JK, Wang
HB and Xu W: Down-regulation of TWIST decreases migration and
invasion of laryngeal carcinoma Hep-2 cells by regulating the
E-cadherin, N-cadherin expression. J Cancer Res Clin Oncol.
137:1487–1493. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang N, Hui L, Wang Y, Yang H and Jiang X:
Overexpression of SOX2 promotes migration, invasion, and
epithelial-mesenchymal transition through the Wnt/β-catenin pathway
in laryngeal cancer Hep-2 cells. Tumour Biol. 35:7965–7973. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stappert J and Kemler R: A short core
region of E-cadherin is essential for catenin binding and is highly
phosphorylated. Cell Adhes Commun. 2:319–327. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Joo YE, Rew JS, Choi SK, Bom HS, Park CS
and Kim SJ: Expression of e-cadherin and catenins in early gastric
cancer. J Clin Gastroenterol. 35:35–42. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kallakury BV, Sheehan CE, Winn-Deen E,
Oliver J, Fisher HA, Kaufman RP Jr and Ross JS: Decreased
expression of catenins (alpha and beta), p120 CTN, and E-cadherin
cell adhesion proteins and E-cadherin gene promoter methylation in
prostatic adenocarcinomas. Cancer. 92:2786–2795. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Andrews NA, Jones AS, Helliwell TR and
Kinsella AR: Expression of the E-cadherin-catenin cell adhesion
complex in primary squamous cell carcinomas of the head and neck
and their nodal metastases. Br J Cancer. 75:1474–1480. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chang CJ, Chao CH, Xia W, Yang JY, Xiong
Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, et al: p53 regulates
epithelial-mesenchymal transition and stem cell properties through
modulating miRNAs. Nat Cell Biol. 13:317–323. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ding W, You H, Dang H, LeBlanc F, Galicia
V, Lu SC, Stiles B and Rountree CB: Epithelial-to-mesenchymal
transition of murine liver tumor cells promotes invasion.
Hepatology. 52:945–953. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wiklund ED, Bramsen JB, Hulf T, Dyrskjøt
L, Ramanathan R, Hansen TB, Villadsen SB, Gao S, Ostenfeld MS,
Borre M, et al: Coordinated epigenetic repression of the miR-200
family and miR-205 in invasive bladder cancer. Int J Cancer.
128:1327–1334. 2011. View Article : Google Scholar : PubMed/NCBI
|
